ALOGLIPTIN AND METFORMIN HYDROCHLORIDE (KAZANO) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

What is the Trade Name for ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

KAZANO

What is the Indication for ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

  • 1 INDICATIONS AND USAGE KAZANO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. KAZANO is a combination of alogliptin, a dipeptidyl-peptidase-4 (DPP-4) inhibitor and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Should not be used in patients with type 1 diabetes mellitus. ( 1 ) Limitations of Use KAZANO should not be used in patients with type 1 diabetes mellitus.

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]